Emergent BioSolutions
EBS
#8133
Rank
S$0.46 B
Marketcap
S$9.04
Share price
3.67%
Change (1 day)
-30.55%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -S$0.13 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are S$0.74 Billion. In 2025 the company made an earning of S$0.18 Billion, an increase over its 2024 earnings that were of -S$92.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.13 Billion-167.73%
2025 S$0.18 B-297.64%
2024 -S$92.07 Million-88.82%
2023 -S$0.83 Billion242.73%
2022 -S$0.25 Billion-153.8%
2021 S$0.44 B-20.43%
2020 S$0.56 B278.02%
2019 S$0.14 B27.11%
2018 S$0.11 B-27.12%
2017 S$0.16 B17.21%
2016 S$0.13 B0.45%
2015 S$0.13 B73.51%
2014 S$78.49 M41.36%
2013 S$55.52 M35.2%
2012 S$41.07 M0.4%
2011 S$40.9 M-56.46%
2010 S$93.94 M76.73%
2009 S$53.15 M32.94%
2008 S$39.98 M-5.62%
2007 S$42.37 M
2005 S$61.34 M269.89%
2004 S$16.58 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.84 B-7,362.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 B-8,186.23%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$10.10 B-8,396.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-S$14.99 Million-87.69%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-S$14.27 Million-88.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.42 Billion 242.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.05 B-1,787.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel